SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tomato who wrote (2671)9/29/2001 10:45:41 PM
From: scaram(o)ucheRead Replies (1) of 4974
 
>> That seemed rather perturbing at the time. <<

Still does. And yet OSIP still makes warm and fuzzy noises re. adenosine receptors.

Remember, however, that the royalty rate is certainly low, and that it would only apply to the first molecule commercialized. We're talking modest. Unless you compare potential to market cap, then the potential royalties look damn big.

Sorry, but the report from the annual meeting bugs me too. I have no answers.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News